Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Patients with Prostate Cancer
100%
Androgen Deprivation Therapy
100%
Response Monitoring
100%
Diffusion Magnetic Resonance Imaging (dMRI)
100%
Dynamic Contrast-enhanced Magnetic Resonance Imaging (DCE-MRI)
50%
Peripheral Zone
33%
Apparent Diffusion Coefficient
33%
Enhanced Diffusion
33%
Tumor
16%
Radiotherapy
16%
Prostate-specific Antigen
16%
Angiogenesis
16%
Advanced Prostate Cancer
16%
Tumor Region
16%
Region of Interest
16%
T2-weighted Imaging (T2WI)
16%
Anatomical Information
16%
Neoadjuvant
16%
Diffusion-weighted Imaging
16%
Tumor Cell Death
16%
Ktrans
16%
Therapy Response
16%
MRI Parameters
16%
Prostate Volume
16%
Dynamic Contrast-enhanced
16%
Androgen Deprivation Therapy Resistance
16%
Residual Tumor
16%
Metastatic Prostate Cancer
16%
Consecutive Patients
16%
Nursing and Health Professions
Prostate Cancer
100%
Androgen Deprivation Therapy
100%
Diffusion Weighted Imaging
100%
Feasibility Study
100%
Neoplasm
42%
Dynamic Contrast-Enhanced MRI
42%
Imaging
28%
Apparent Diffusion Coefficient
28%
Prostate Specific Antigen
14%
Radiotherapy
14%
Treatment Response
14%
Cell Death
14%
Prostate Volume
14%
Therapy Resistance
14%
Medicine and Dentistry
Prostate Cancer
100%
Androgen Deprivation Therapy
100%
Diffusion MRI
100%
Dynamic Contrast-Enhanced MRI
42%
Neoplasm
28%
Prostate Specific Antigen
14%
Treatment Response
14%
Radiation Therapy
14%
Cell Death
14%
Angiogenesis
14%
Tumor Cell
14%
Therapy Resistance
14%
Tumor
14%
Neuroscience
Androgen
100%
Diffusion MRI
100%
Magnetic Resonance Imaging
42%
Prostate
28%
Angiogenesis
14%
Prostate Specific Antigen
14%
Radiation Therapy
14%
Cell Death
14%